Technical Charting - Sun Pharmaceutical Industries Ltd.
Search Company
Registered Address
Registered Office : Sun Pharma Advanced Research Centre (SPARC), Tandalja,
Vadodra, Gujarat - 390012
Tel: 0265-6615500, 6615600, 6615700
Fax: 0265-2354897
Email : secretarial@sunpharma.com
Website : http://www.sunpharma.com
Key Officials
Name Designation
Mr. Anoop Deshpande Co. Secretary & Compl. Officer
Mr. Abhay Gandhi CEO - North America
Mr. Kirti Ganorkar Head - Business Process
Listings
BSE , BSE , MCXSX , NSE , NSE ,  
Standalone Consolidated
You are viewing standalone data.
Quarterly Results
Mar 26 Dec 25 Sep 25
Sales 4,923.88 5,687.77 4,548.11
Other Income 62.93 179.90 72.79
Total Expenses 3,283.00 3,515.90 3,026.43
Operating Profit 1,640.88 2,171.87 1,521.68
Interest 216.92 244.17 248.33
Gross Profit 1,174.98 1,694.33 1,008.05
Provisions Made 0.00 0.00 0.00
Depreciation 325.97 338.53 336.30
Taxation 215.02 482.06 107.53
Net Profit / Loss 608.70 705.44 564.22
Equity Capital 239.93 239.93 239.93
Balance Sheet
Mar 26 Mar 25 Mar 24
Share Capital 239.93 239.93 239.93
Reserve & Surplus 22,130.83 24,099.92 23,454.47
Revaluation Reserve 0.00 0.00 0.00
Networth 22,370.76 24,339.85 23,694.40
Total debt 13,419.99 10,954.47 11,046.61
Total Liability 35,790.75 35,294.32 34,741.01
Net Block 8,512.48 6,988.52 7,736.74
Capital work in progress 0.00 939.23 766.11
Investment 12,951.56 12,410.11 12,429.97
Net current asset 14,326.71 14,956.46 13,808.19
Miscellaneous expenses 0.00 0.00 0.00
Total Assets 35,790.75 35,294.32 34,741.01
Income Statement
  Mar26 Mar25 Mar24
Sales 20,754.64 23,003.33 20,275.17
Other Income 419.33 369.43 465.76
Total Expenses 14,573.95 16,210.71 14,687.56
Operating Profit 6,180.69 6,792.62 5,587.61
Interest 947.84 893.21 784.08
Adjusted PBDIT 6,600.02 7,162.05 6,053.37
Depreciation 1,311.72 1,238.27 1,600.62
Adjusted PBT 4,340.46 5,030.57 3,668.67
Taxation 1,336.32 747.95 591.47
Net Profit / Loss 2,623.42 4,282.62 2,858.18
Key Ratios
  Mar26 Mar25 Mar24
OPM (%) 29.77 29.52 27.55
GPM (%) 23.45 24.14 19.66
NPM (%) 12.64 18.61 14.09
Earning Retention Ratio 100.00 15.62 5.82
Return on networth (%) 11.72 17.59 12.06
EPS (Rs.) 10.93 17.85 11.91
Dividend payout Ratio 0.00 84.38 101.39
Longterm Debt-Equity Ratio 0.59 0.00 0.46
Current Ratio 2.97 2.87 3.18
Fixed Asset Turnover Ratio 0.58 0.65 0.61
Inventory 0.57 0.65 0.58
Interest coverage Ratio 6.96 8.02 7.72
Registrar Details
MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel : 022-49186270
Fax : 49186060
Market Performance
Exchange BSE NSE
Last Traded Price (Rs.) 1,788.60 1,788.80
Last Traded Date 08/06/2026 08/06/2026
Last Traded Time - -
Change (%) 0.28% 0.37%
Day's Open (Rs.) 1,774.85 1,780.70
Previous Close (Rs.) 1,783.55 1,782.20
Day's High (Rs.) 1,802.70 1,803.50
Day's Low (Rs.) 1,774.50 1,773.50
Volume (Rs. In Lacs) 1304.67 55571.40
Bid Price (Rs.) 0.00 0.00
Bid Quantity
Offer Price (Rs.) 0.00 0.00
Offer Quantity
Exchange Code 524715 SUNPHARMAEQ
Exchange Group A Nifty
Board Meetings
Date Purpose
22/05/2026 Audited Results & Final Dividend
31/01/2026 Quarterly Results & Interim Dividend
05/11/2025 Quarterly Results
Corporate News
Sun Pharmaceutical - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Sun Pharmaceutical - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sun Pharmaceutical - Analysts/Institutional Investor Meet/Con. Call Updates
Sun Pharmaceutical - Filing Of Application For Reclassification With Stock Exchanges
Sun Pharmaceutical - General Updates
Share Holding Pattern as on 31/03/2026
Major Holder No. of Shares Percentage (%)
Promoters 1,307,119,535 54.48
Institutional Investors 888,727,310 37.04
Other Investors 76,215,224 3.18
General Public 127,272,901 5.30